patientfull.jpg
PE Fundraising

Altas Partners closes $4B fund with patient deal approach

Altas Partners closed its third fund on $4 billion, a testament to its patient investment thesis.

Altas Partners closed its third PE fund Wednesday, Altas Partners Holdings III, on $4 billion, with backing from some of North America’s largest institutional investors.

The fund attracted commitments from LPs including Alaska Permanent Fund, which allocated $40 million and $50 million to its predecessor, and the San Mateo County Employees’ Retirement Association, which committed $25 million in 2022.

The new fund is a third larger than its $3 billion predecessor and will continue Altas’ strategy of targeting five to seven businesses to own and grow, as well as continuing its focus on the healthcare, business services and specialized industrial sectors. Altas executes one or two deals a year at anywhere from $400 million to $1 billion each, and while its holding periods tend to follow PE’s typical five to seven years, its fund structure allows for an extension when necessary.

“We make sure that our investors understand that if a year goes by and we don’t buy a business, that needs to be OK,” said Aryella Frommer, head of investor relations at Altas.

Since the Toronto-based firm’s inception in 2012, it has acquired 10 businesses and expects to complete its 11th investment in the next few months—its first acquisition in over two years. The firm’s current portfolio companies include Unified Women’s Healthcare, an OB-GYN physician practice management company acquired in a 2020 partnership with Ares Management; fire protection services company Pye-Barker Fire; and chemical supplier DuBois Chemicals.

Wednesday’s fund close is a testament to the strength of the differentiation its strategy can provide to LPs, Frommer said, particularly in the current PE fundraising environment.

“We’re trying to avoid the potential pitfalls of falling into a cycle of deployment of the need to put capital to work,” she said. “It’s so important that we find investors and folks at the firm who are enthused by the pursuit of funding the right opportunity, the best of everything they see, as opposed to those investors who are motivated by transactions, or deal junkies.”

Amid valuation concerns, last year’s denominator effect on institutional portfolios and the rising cost of debt financing limiting capital deployment, commitments to the asset class declined 41.9% in Q1 2023 year-over-year at the six largest public alternatives managers—Blackstone, KKR, Apollo Global Management, The Carlyle Group, Ares and TPG. Median deployment among the firms also declined 71.4% in the same period, according to PitchBook’s Q1 2023 US Public PE and GP Deal Roundup.

While LPs tend to allocate to experienced funds with established track records in periods of uncertainty, current fundraising challenges are hitting all investor types. From Q1 2022 to Q1 2023, fundraising for experienced PE managers fell 18% and fundraising for emerging managers fell 8%, according to PitchBook’s Q1 2023 Global Private Market Fundraising Report.

 

Altas’ Fund II closed in 2019 at triple the size of the first fund in the series—which closed in 2016 on $1 billion—and garnered commitments from institutional investors including the Louisiana State Employees’ Retirement System, which had a $94.2 million allocation to the fund, and the Employees Retirement System of Ohio, which committed $50 million.

“We’ve been fortunate in that we have had the opportunity to build long-lasting partnerships with many of our investors,” said Frommer.


Featured image by Min C. Chiu/Shutterstock

Learn about our editorial standards.